Commercializing Cell and Gene Therapies
Cell and gene therapies coming to market hold the potential to redefine every commercialization paradigm – from how products come to market, to how the therapies are transported, to how patients and providers are supported. What can therapy innovators do to ensure commercial success?
Experts at AmerisourceBergen have released a new, interactive whitepaper in which they offer more than 70 pages of practical insights on what it takes to execute an effective commercialization strategy in this burgeoning space. Spanning issues as diverse as health economics, specialty logistics and patient access, this digital experience addresses key questions along the cell and gene therapy commercialization journey.
You can also listen to a related podcast entitled “How to Navigate Specialty Logistics for Cell and Gene Therapies.”